Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Upadacitinib may effectively treat alopecia areata without side effects.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Finasteride improved hidradenitis suppurativa in kids without side effects.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.